Merrimack Pharmaceuticals Inc. (MACK) Declined -6.33% or -0.4 To Price $5.84 On Friday


Merrimack Pharmaceuticals Inc. (MACK) declined -6.33% or -0.4 to $5.84. It is near to 145278 shares traded, which is 416.53% compare to the average total volume 34878. The market cap of MACK is $77.99 million. The year to date change is 47.36%. The 52 week price range is from $3.34 to $10.53. Price of MACK have changed -0.16% during last week. It have changed -5.45% over last month, 2.13% over last 3 months, 41.18% over last 6 months and -25.54% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 6.27. It is 7.36% above current price. The 200-day Moving Averages for MACK is 5.41. It is -7.36% below current price. The 52-week High is 10.53. It is 80.31% from the current price. The 52-week Low is 3.34. It is -42.81% from current price.

There are some statistics of MACK. It is has market cap $77.99 million. The share outstanding is 13.34 million. The average volume is 34878. The percent of top 15 Institution holding is 56.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -54.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is -40.67%.


Tags:

Share this post